31 assistant-professor-and-human-centered-computing PhD positions at University of Cambridge in Uk
-
The Centre for Doctoral Training in Nanoscience and Nanotechnology (NanoDTC) at the University of Cambridge invites applications for its 3.5-year interdisciplinary PhD programme. The programme
-
Targeting Cardiometabolic Dysfunction in Heart Failure with Preserved Ejection Fraction (HFpEF): Mechanisms of Exercise-Induced Protection Overview Applications are invited for a fully funded 4-year
-
Supervisor: Professor Richard Gilbertson and Dr Giulia Biffi For further information about the research group, please visit biffilab.wordpress.com . Project details Cancer-associated fibroblasts
-
We invite applications from creative and motivated individuals to join Professor Sir Shankar Balasubramanian's group for a 4-year PhD studentship, working on a multidisciplinary project exploiting
-
(NP) led by Professor Jeremy J Baumberg, FRS (https://www.np.phy.cam.ac.uk/ ), as part of UK targeted collaboration on 3D Metamaterials. Metamaterials provide emergent properties by combining nano-scale
-
PhD studentship: Defining the role of the pioneer factor FOXA1 in hormone-dependent cancer Supervisor: Professor Jason Carroll Course start date: 1st October 2026 Project details For further
-
Supervisor: Professor Jason Carroll Course start date: 1st October 2026 Project details For further information about the research group, including their most recent publications, please visit
-
£19,000 per year. Applications for this PhD studentship should be submitted via the University of Cambridge Applicant Portal www.graduate.study.cam.ac.uk/courses/directory/egegpdpeg , with Professor Duncan
-
-energizing exhausted T cells, it is becoming apparent that many checkpoint drugs act on specific subsets of ‘stem like’ T cells, which are present in the lymph nodes, or other sites such as the tumour itself
-
Applications are invited for a fully funded 4-year PhD studentship based in the Department of Biochemistry, University of Cambridge, and the new AstraZeneca Discovery Centre in Cambridge